TY - JOUR
T1 - Longitudinal Angiographic Evidence That Intraretinal Microvascular Abnormalities Can Evolve into Neovascularization
AU - Russell, Jonathan F.
AU - Shi, Yingying
AU - Scott, Nathan L.
AU - Gregori, Giovanni
AU - Rosenfeld, Philip J.
N1 - Funding Information:
Supported by Carl Zeiss Meditec, Inc, Dublin, California; the Salah Foundation; Research to Prevent Blindness, Inc, New York, New York (unrestricted grant); the National Eye Institute, National Institutes of Health, Bethesda, Maryland (Center Core grant no.: P30EY014801 [Department of Ophthalmology, University of Miami Miller School of Medicine]); and the Heed Foundation (J.F.R., N.L.S.). The funding organizations had no role in the design or conduct of this research.
Funding Information:
Supported by Carl Zeiss Meditec , Inc, Dublin, California; the Salah Foundation; Research to Prevent Blindness , Inc, New York, New York (unrestricted grant); the National Eye Institute , National Institutes of Health , Bethesda, Maryland (Center Core grant no.: P30EY014801 [Department of Ophthalmology, University of Miami Miller School of Medicine]); and the Heed Foundation (J.F.R., N.L.S.). The funding organizations had no role in the design or conduct of this research.
Publisher Copyright:
© 2020 American Academy of Ophthalmology
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/12
Y1 - 2020/12
N2 - Purpose: The hallmark of proliferative diabetic retinopathy (PDR) is retinal neovascularization. Tortuous intraretinal vascular segments known as intraretinal microvascular abnormalities (IRMAs) are a known risk factor for neovascularization (NV), but whether IRMA represents a biomarker or a vascular precursor lesion to NV has not been demonstrated. The purpose of this study was to determine whether IRMA may evolve directly into NV. Design: Retrospective analysis of prospective, observational case series. Participants: Patients with treatment-naïve PDR. Methods: Patients were imaged longitudinally with fluorescein angiography (FA) and swept-source (SS) OCT angiography (OCTA) before and after panretinal photocoagulation (PRP). Main Outcome Measures: Presence and colocalization of IRMA and NV on serial FA and SS OCTA. Results: Two PDR patients showed multiple NV and IRMA lesions at baseline examination. Three months after PRP, FA demonstrated profuse leakage from 3 new NV lesions in one patient and 1 new NV lesion in another patient. Multimodal imaging showed that these 4 lesions were IRMAs at baseline. Swept-source OCTA performed before PRP and 1 week, 1 month, and 3 months after PRP confirmed that the precursor IRMA lesions were intraretinal tortuous vascular lesions at baseline and that they developed into preretinal NV with contiguous intraretinal components. NV was found to develop and adhere to the posterior hyaloid even in areas of pre-existing hyaloidal detachment. Conclusions: Diabetic retinal NV can develop from IRMA. Early identification of IRMAs may be an accurate means of predicting progression to PDR, and frequent monitoring of IRMAs with SS OCTA may facilitate early diagnosis of PDR.
AB - Purpose: The hallmark of proliferative diabetic retinopathy (PDR) is retinal neovascularization. Tortuous intraretinal vascular segments known as intraretinal microvascular abnormalities (IRMAs) are a known risk factor for neovascularization (NV), but whether IRMA represents a biomarker or a vascular precursor lesion to NV has not been demonstrated. The purpose of this study was to determine whether IRMA may evolve directly into NV. Design: Retrospective analysis of prospective, observational case series. Participants: Patients with treatment-naïve PDR. Methods: Patients were imaged longitudinally with fluorescein angiography (FA) and swept-source (SS) OCT angiography (OCTA) before and after panretinal photocoagulation (PRP). Main Outcome Measures: Presence and colocalization of IRMA and NV on serial FA and SS OCTA. Results: Two PDR patients showed multiple NV and IRMA lesions at baseline examination. Three months after PRP, FA demonstrated profuse leakage from 3 new NV lesions in one patient and 1 new NV lesion in another patient. Multimodal imaging showed that these 4 lesions were IRMAs at baseline. Swept-source OCTA performed before PRP and 1 week, 1 month, and 3 months after PRP confirmed that the precursor IRMA lesions were intraretinal tortuous vascular lesions at baseline and that they developed into preretinal NV with contiguous intraretinal components. NV was found to develop and adhere to the posterior hyaloid even in areas of pre-existing hyaloidal detachment. Conclusions: Diabetic retinal NV can develop from IRMA. Early identification of IRMAs may be an accurate means of predicting progression to PDR, and frequent monitoring of IRMAs with SS OCTA may facilitate early diagnosis of PDR.
UR - http://www.scopus.com/inward/record.url?scp=85088803221&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088803221&partnerID=8YFLogxK
U2 - 10.1016/j.oret.2020.06.010
DO - 10.1016/j.oret.2020.06.010
M3 - Article
C2 - 32544625
AN - SCOPUS:85088803221
VL - 4
SP - 1146
EP - 1150
JO - Ophthalmology Retina
JF - Ophthalmology Retina
SN - 2468-7219
IS - 12
ER -